Recreational cannabis legalization alters associations among cannabis use, perception of risk, and cannabis use disorder treatment for adolescents and young adults

Mennis, Jeremy; McKeon, Thomas P.; Stahler, Gerald J.

doi:10.1016/j.addbeh.2022.107552

Cited by 40 publications

(18 citation statements)

References 54 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…3,4 The increase in cannabis use in the US is not restricted to younger individuals but is also observed for middle-aged and older adults (Figure 2), age groups with the highest prevalence of chronic nonpsychiatric health conditions. [5][6][7][8] In agreement, adults with underlying medical conditions were more likely to use cannabis compared with adults without these conditions, and many users attributed their consumption to symptoms that frequently co-occur with gastrointestinal (GI) disorders including pain, nausea, stress, and poor sleep. 9,10 Additionally, several debilitating GI diseases are listed as qualifying conditions for medical cannabis use, including inflammatory bowel disease (IBD) and GI cancer.…”

Section: Cannabis Use Trends In the United Statesmentioning

confidence: 93%

Cannabis use in the United States and its impact on gastrointestinal health

Alshaarawy,

Balasubramanian,

Venkatesan

2023

Nut in Clin Prac

View full text Add to dashboard Cite

In recent years, the legalization and social acceptability of cannabis use have increased in the United States. Concurrently, the prevalence of cannabis use has continued to rise, and cannabis products have diversified. There are growing concerns regarding the health effects of regular and high‐potency cannabis use, and new research has shed light on its potentially negative effects. Here, we review evidence of the gastrointestinal (GI) effects of cannabis and cannabinoids. Dysregulation of the endocannabinoid system might contribute to various GI disorders, including irritable bowel syndrome and cyclic vomiting syndrome, and endocannabinoids have been found to regulate visceral sensation, nausea, vomiting, and the gut microbiome. Cannabis has been shown to have antiemetic properties, and the US Food and Drug Administration has approved cannabis‐based medications for treating chemotherapy‐induced nausea and vomiting. Yet, chronic heavy cannabis use has been linked to recurrent episodes of severe nausea and intractable vomiting (cannabinoid hyperemesis syndrome). Given the considerable heterogeneity in the scientific literature, it is unclear if cannabinoid hyperemesis syndrome is truly a distinct entity or a subtype of cyclic vomiting that is unmasked by heavy cannabis use and the associated dysregulation of the endocannabinoid system. The changes in cannabis legalization, availability, and public risk perceptions have outpaced research in this area and there is a need for robust, prospective, large‐scale studies to understand the effects of cannabis use on GI health.

show abstract

Section: Cannabis Use Trends In the United Statesmentioning

confidence: 93%

Cannabis use in the United States and its impact on gastrointestinal health

Alshaarawy,

Balasubramanian,

Venkatesan

2023

Nut in Clin Prac

View full text Add to dashboard Cite

show abstract

“…One found increased past-month cannabis use prevalence for both adolescents (age 12–17) and young adults (18–25) along with a declined perception of risk of harm from use among young adults, following RCL. Lower risk perception was significantly associated with higher use among both adolescents and young adults with associations becoming stronger after legalization [12 ▪ ]. However, another found no effect of RCL on the occurrence of newly incident cannabis onsets for underage persons (<21 years), either after the legalization date ( P = 0.27) or the effective date ( P = 0.53) [13 ▪ ].…”

Section: Cannabis Use Among Adolescents and Young Peoplementioning

confidence: 94%

“…Two studies used data of 2008 to 2019 waves from the National Surveys on Drug Use and Health (NSDUH) [12 ▪ ,13 ▪ ] in all US states. One found increased past-month cannabis use prevalence for both adolescents (age 12–17) and young adults (18–25) along with a declined perception of risk of harm from use among young adults, following RCL.…”

Section: Cannabis Use Among Adolescents and Young Peoplementioning

confidence: 99%

Effects of cannabis legalization on the use of cannabis and other substances

Assanangkornchai

Kalayasiri

Ratta‐apha

et al. 2023

Current Opinion in Psychiatry

View full text Add to dashboard Cite

Purpose of reviewAs more jurisdictions legalize cannabis for non-medical use, the evidence on how legalization policies affect cannabis use and the use of other substances remains inconclusive and contradictory. This review aims to summarize recent research findings on the impact of recreational cannabis legalization (RCL) on cannabis and other substance use among different population groups, such as youth and adults. Recent findingsRecent literature reports mixed findings regarding changes in the prevalence of cannabis use after the adoption of RCL. Most studies found no significant association between RCL and changes in cannabis use among youth in European countries, Uruguay, the US, and Canada. However, some studies have reported increases in cannabis use among youth and adults in the US and Canada, although these increases seem to predate RCL. Additionally, there has been a marked increase in unintentional pediatric ingestion of cannabis edibles postlegalization, and an association between RCL and increased alcohol, vaping, and e-cigarette use among adolescents and young adults. SummaryOverall, the effects of cannabis legalization on cannabis use appear to be mixed. Further monitoring and evaluation research is needed to provide longer-term evidence and a more comprehensive understanding of the effects of RCL.

show abstract

“…Studies show an increase in consumption due to legalization in the United States. The most recent ones, such as that of Mennis et al (2023), show that after the legalization of recreational marijuana, there was an increase in consumption, especially among teenagers. Additionally, researchers have found an increased frequency of marijuana use and a higher prevalence of symptoms associated with marijuana use disorder (Kilmer et al, 2022).…”

Section: Introductionmentioning

confidence: 99%

Marijuana on Main Streets? The Story Continues in Colombia: An Endogenous Three-part Model

Hassan

2023

SSRN Journal

View full text Add to dashboard Cite

Recreational cannabis legalization alters associations among cannabis use, perception of risk, and cannabis use disorder treatment for adolescents and young adults

Cited by 40 publications

References 54 publications

Cannabis use in the United States and its impact on gastrointestinal health

Cannabis use in the United States and its impact on gastrointestinal health

Effects of cannabis legalization on the use of cannabis and other substances

Marijuana on Main Streets? The Story Continues in Colombia: An Endogenous Three-part Model

Contact Info

Product

Resources

About